Listed

Brady Corp: Form 10-Q for the period ended Jan 31, 2020

Filed with the SEC on Feb 20, 2020 and accepted by EDGAR at Feb 20, 2020, 07:08 ET.

Share

Management's discussion and analysis

As filed, 27,349 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Overview

Brady Corporation is a global manufacturer and supplier of identification solutions and workplace safety products that identify and protect premises, products and people. The IDS segment is primarily involved in the design, manufacture, and distribution of high-performance and innovative identification and healthcare products. The WPS segment provides workplace safety and compliance products, approximately half of which are internally manufactured and half of which are externally sourced.

The long-term sales growth and profitability of our segments will depend not only on improved demand in end markets and the overall economic environment, but also on our ability to continuously improve operational excellence, focus on the customer, develop and market innovative new products, and to advance our digital capabilities. In our Identification Solutions ("ID Solutions" or "IDS") business, our strategy for growth includes an increased focus on certain industries and products, a focus on improving the customer buying experience, and investing in research and development ("R&D") to develop new products. In our Workplace Safety ("WPS") business, our strategy for growth includes a focus on workplace safety critical industries, innovative new product offerings, compliance expertise, customization expertise, and improving our digital capabilities.

The following are key initiatives supporting the strategy in fiscal 2020:

  • Enhancing our research and development process and improving the time to launch high-value, innovative products in alignment with our target markets.
  • Providing our customers with the highest level of customer service.
  • Driving operational excellence and executing sustainable efficiency gains within our global operations and within our selling, general and administrative structures.
  • Expanding and enhancing our sales capabilities through an improved digital presence and increased sales resources.
  • Growing through focused actions in selected vertical markets and strategic accounts.
  • Enhancing our employee development process to create an engaged workforce and to attract and retain key talent.

Results of Operations

A comparison of results of operating income for the three and six months ended January 31, 2020 and 2019, is as follows:

(Dollars in thousands)

Three months ended January 31, 2020 % Sales 2019 % Sales Six months ended January 31, 2020 % Sales 2019 % Sales
Net sales $276,665 $282,426 $563,612 $575,622
Gross margin 139,127 50.3% 139,810 49.5% 280,532 49.8% 286,349 49.7%
Operating expenses:
Research and development 10,517 3.8% 11,074 3.9% 21,484 3.8% 22,400 3.9%
Selling, general and administrative 87,366 31.6% 92,706 32.8% 176,913 31.4% 187,297 32.5%
Total operating expenses 97,883 35.4% 103,780 36.7% 198,397 35.2% 209,697 36.4%
Operating income $41,244 14.9% $36,030 12.8% $82,135 14.6% $76,652 13.3%

References in this Form 10-Q to “organic sales” refer to sales calculated in accordance with GAAP, excluding the impact of foreign currency translation. The Company's organic sales disclosures exclude the effects of foreign currency translation as foreign currency translation is subject to volatility that can obscure underlying business trends. Management believes that the non-GAAP financial measure of organic sales is meaningful to investors as it provides them with useful information to aid in identifying underlying sales trends in our businesses and facilitating comparisons of our sales performance with prior periods.

Sales for the three months ended January 31, 2020, decreased 2.0% to $276.7 million, compared to $282.4 million in the same period of the prior year. The decrease consisted of an organic sales decline of 1.2% and a decrease from foreign currency translation of 0.8%. Organic sales declined 1.3% in the IDS segment and declined 1.0% in the WPS segment during the three months ended January 31, 2020, compared to the same period in the prior year.

Sales for the six months ended January 31, 2020, decreased 2.1% to $563.6 million, compared to $575.6 million in the same period of the prior year. The decrease consisted of an organic sales decline of 0.8% and a decrease from foreign currency translation of 1.3%. Organic sales declined 0.7% in the IDS segment and declined 0.9% in the WPS segment during the six months ended January 31, 2020, compared to the same period in the prior year.

Gross margin decreased 0.5% to $139.1 million and decreased 2.0% to $280.5 million for the three and six months ended January 31, 2020, respectively, compared to $139.8 million and $286.3 million in the same periods of the prior year. As a percentage of net sales, gross margin increased to 50.3% and 49.8% for the three and six months ended January 31, 2020, respectively, compared to 49.5% and 49.7% in the same periods of the prior year. The increase in gross margin as a percentage of net sales was primarily due to our ongoing efforts to streamline manufacturing processes and drive operational efficiencies, including increased automation in our manufacturing facilities, which were partially offset by increased input costs such as personnel and freight costs, along with reduced sales volume.

R&D expenses decreased 5.0% to $10.5 million and decreased 4.1% to $21.5 million for the three and six months ended January 31, 2020, respectively, compared to $11.1 million and $22.4 million in the same periods of the prior year. As a percentage of sales, R&D expenses remained consistent for the three and six months ended January 31, 2020, compared to the same periods of the prior year. The decrease in R&D spending for both the three and six-month periods was primarily due to the timing of expenditures related to ongoing new product development projects. The Company remains committed to investing in new product development to increase sales within our IDS and WPS businesses. Investments in new printers and materials continue to be the primary focus of R&D expenditures.

Selling, general and administrative expenses ("SG&A") include selling and administrative costs directly attributed to the IDS and WPS segments, as well as certain other administrative expenses including finance, information technology, human resources, and other administrative expenses. SG&A decreased 5.8% to $87.4 million and decreased 5.5% to $176.9 million for the three and six months ended January 31, 2020, respectively, compared to $92.7 million and $187.3 million in the same periods of the prior year. As a percentage of sales, SG&A was 31.6% and 31.4% for the three and six months ended January 31, 2020, respectively, compared to 32.8% and 32.5% in the same periods of the prior year. Approximately one-fourth of the decrease in both the three and six-month periods was due to the impact of foreign currency translation, and the remainder was due to ongoing efficiency gains and lower compensation expense.

Operating income increased 14.5% to $41.2 million for the three months ended January 31, 2020, and 7.2% to $82.1 million for the six months ended January 31, 2020, compared to $36.0 million and $76.7 million in the same periods of the prior year, respectively. The increases in both the three and six-month periods were primarily due to increased segment profit within both the IDS and WPS businesses along with reduced corporate administrative expenses.

OPERATING INCOME TO NET INCOME

(Dollars in thousands)

Three months ended January 31, 2020 % Sales 2019 % Sales Six months ended January 31, 2020 % Sales 2019 % Sales
Operating income $41,244 14.9% $36,030 12.8% $82,135 14.6% $76,652 13.3%
Other income (expense):
Investment and other income 1,760 0.6% 1,377 0.5% 3,140 0.6% 1,360 0.2%
Interest expense (647) (0.2)% (717) (0.3)% (1,348) (0.2)% (1,429) (0.2)%
Income before income tax 42,357 15.3% 36,690 13.0% 83,927 14.9% 76,583 13.3%
Income tax expense 8,804 3.2% 7,463 2.6% 12,876 2.3% 16,719 2.9%
Net income $33,553 12.1% $29,227 10.3% $71,051 12.6% $59,864 10.4%

Investment and other income was $1.8 million and $3.1 million for the three and six months ended January 31, 2020, respectively, compared to $1.4 million in each of the same periods of the prior year. The increases in both the three and six-month periods were primarily due to an increase in the market value of securities held in deferred compensation plans and an increase in interest income when compared to the same periods in the prior year.

Interest expense remained essentially flat at $0.6 million and $1.3 million for the three and six months ended January 31, 2020, respectively, compared to $0.7 million and $1.4 million in the same periods of the prior year, as there was minimal change in the Company's principal balance under its outstanding debt agreements.

The Company's income tax rate was 20.8% for the three months ended January 31, 2020, compared to 20.3% for the same period in the prior year. The income tax rate was 15.3% for the six months ended January 31, 2020, compared to 21.8% for the same period in the prior year. Refer to Note M - Income Taxes for additional information on the Company's income tax rate.

Business Segment Operating Results

The Company evaluates short-term segment performance based on segment profit and customer sales. Interest expense, investment and other income, income tax expense, and certain corporate administrative expenses are excluded when evaluating segment performance.

The following is a summary of segment information for the three and six months ended January 31, 2020, and 2019:

SALES GROWTH INFORMATION ID Solutions Three months ended January 31, 2020 2019 Six months ended January 31, 2020 2019
Organic (1.3)% 3.6% (0.7)% 4.6%
Currency (0.5)% (2.3)% (0.9)% (1.9)%
Total (1.8)% 1.3% (1.6)% 2.7%
Workplace Safety
Organic (1.0)% (0.9)% (0.9)% 0.6%
Currency (1.6)% (3.3)% (2.5)% (2.9)%
Divestitures —% (5.8)% —% (6.0)%
Total (2.6)% (10.0)% (3.4)% (8.3)%
Total Company
Organic (1.2)% 2.3% (0.8)% 3.5%
Currency (0.8)% (2.6)% (1.3)% (2.2)%
Divestitures —% (1.6)% —% (1.7)%
Total (2.0)% (1.9)% (2.1)% (0.4)%
SEGMENT PROFIT AS A PERCENT OF NET SALES
ID Solutions 19.8% 18.1% 19.8% 18.6%
Workplace Safety 7.7% 6.4% 7.4% 6.9%
Total 16.7% 15.1% 16.6% 15.6%

ID Solutions

IDS net sales decreased 1.8% in the three months ended January 31, 2020, compared to the same period in the prior year, which consisted of an organic sales decline of 1.3% and a decrease from foreign currency translation of 0.5%. Organic sales in the three-month period were essentially flat in the Safety and Facility ID and Product ID product lines while the Healthcare ID and Wire ID product lines declined compared to the prior year. IDS net sales decreased 1.6% in the six months ended January 31, 2020, compared to the same period in the prior year, which consisted of an organic sales decline of 0.7% and a decrease from foreign currency translation of 0.9%. Organic sales in the six-month period grew in the Safety and Facility ID product line, remained essentially flat in the Product ID product line, and declined in the Healthcare ID and Wire ID product lines compared to the same period in the prior year.

Organic sales in the Americas decreased slightly in the three months ended January 31, 2020, compared to the same period in the prior year. Organic sales in the three-month period were essentially flat in the Safety and Facility ID and Product ID product lines while the Healthcare ID and Wire ID product lines declined compared to the same period in the prior year due to reduced demand in end markets. Organic sales were flat in the United States and declined in the low-single digits in the rest of the Americas in the three-month period. Organic sales in the Americas increased in the low-single digits for the six months ended January 31, 2020, compared to the same period in the prior year. Organic sales in the six-month period grew in the Safety and Facility ID product line, remained essentially flat in the Product ID product line, and declined in the Healthcare ID and Wire ID product lines compared to the same period in the prior year due to reduced demand in end markets. Organic sales grew in the low-single digits in the United States and declined in the low-single digits in the rest of the Americas in the six-month period.

Organic sales in Europe decreased in the low-single digits in the three months ended January 31, 2020, compared to the same period in the prior year. Slight organic sales growth in the Safety and Facility ID product line was more than offset by declines in the Product ID and Wire ID product lines in the three-month period. The organic sales decline in the three-month period was driven by certain businesses based in Western Europe due to a decline in economic activity. Organic sales in Europe decreased in the mid-single digits for the six months ended January 31, 2020, compared to the same period in the prior year, which was driven by a decline in all product lines. The organic sales decline in the six-month period was driven by certain businesses based in emerging geographies and in Western Europe due to a decline in economic activity.

Organic sales in Asia decreased in the mid-single digits in both the three and six months ended January 31, 2020, compared to the same periods in the prior year. Organic sales growth in the Wire ID product line was more than offset by declines in the Safety and Facility ID and Product ID product lines in both the three and six-month periods. Organic sales within China declined approximately 10% and declined in the high-single digits in the three and six-month periods, respectively, partially due to the direct and indirect impact of tariffs and overall economic weakness. Organic sales were essentially flat and declined slightly in the rest of Asia in the three and six-month periods, respectively.

Segment profit increased to $40.7 million and $83.1 million for the three and six months ended January 31, 2020, respectively, compared to $37.9 million and $79.4 million for the same periods in the prior year. As a percentage of net sales, segment profit increased to 19.8% for both the three and six months ended January 31, 2020, from 18.1% and 18.6% for the same periods in the prior year. The increase in segment profit for both the three and six-month periods was primarily driven by efficiency gains throughout SG&A in all regions.

Workplace Safety

WPS net sales decreased 2.6% in the three months ended January 31, 2020, compared to the same period in the prior year, which consisted of an organic sales decline of 1.0% and a decrease from foreign currency translation of 1.6%. WPS net sales decreased 3.4% in the six months ended January 31, 2020, compared to the same period in the prior year, which consisted of an organic sales decline of 0.9% and a decrease from foreign currency translation of 2.5%. Sales through the digital channel grew in the mid-single digits while sales through the catalog channel declined in the low-single digits in both the three and six-month periods.

Organic sales in Europe were effectively flat in the three months and increased modestly in the six months ended January 31, 2020, compared to the same periods in the prior year. Organic sales growth in France was largely offset by a decline in sales in Germany due to reduced demand for industrial products. Sales through the digital channel grew approximately 10% while sales through the catalog channel declined in the low-single digits in both the three and six-month periods.

Organic sales in the Americas decreased in the low-single digits in both the three and six months ended January 31, 2020, respectively, compared to the same periods in the prior year. Catalog channel sales declined in the low-single digits due to lower response rates to catalog promotions in both the three and six-month periods. Digital sales declined in the low-single digits in both the three and six-month periods. This business continued to experience a negative impact on sales from a digital platform that was implemented toward the end of fiscal 2018. In order to address this decline, the business transitioned to a new digital platform mid-way through fiscal 2019. The functionality of the new digital platform has improved compared to the former digital platform. However, sales have not yet returned to the level experienced prior to the initial platform change in fiscal 2018.

Organic sales in Australia were effectively flat in the three months ended January 31, 2020, compared to the same period in the prior year. Digital channel sales increased nearly 12% during the three-month period ended January 31, 2020, which was largely offset by a low-single digit decline in catalog channel sales. Organic sales decreased in the low-single digits in the six months ended January 31, 2020, compared to the same period in the prior year. Low-single digit organic growth in digital sales was offset by a low-single digit decline in catalog sales in the six-month period. We continue to experience reduced demand in primary end markets, which include non-residential construction and industrial manufacturing.

Segment profit increased to $5.5 million and $10.6 million for the three and six months ended January 31, 2020, respectively, compared to $4.7 million and $10.2 million for the same periods in the prior year. As a percentage of net sales, segment profit increased to 7.7% and 7.4% for the three and six months ended January 31, 2020, respectively, compared to 6.4% and 6.9% for the same periods in the prior year. The increases in segment profit were due to efficiency gains throughout SG&A, which were partially offset by the decrease in organic sales and foreign currency translation.

Financial Condition

Cash and cash equivalents were $289.8 million at January 31, 2020, an increase of $10.7 million from July 31, 2019. The significant changes were as follows:

(Dollars in thousands)

Net cash flow provided by (used in): Six months ended January 31, 2020 2019
Operating activities $53,107 $44,188
Investing activities (16,506) (12,579)
Financing activities (26,049) (10,051)
Effect of exchange rate changes on cash 179 (776)
Net increase in cash and cash equivalents $10,731 $20,782

Net cash provided by operating activities was $53.1 million for the six months ended January 31, 2020, compared to $44.2 million in the same period of the prior year. The increase was primarily driven by an increase in net income adjusted for non-cash items as well as a decrease in cash used for working capital.

Net cash used in investing activities was $16.5 million for the six months ended January 31, 2020, compared to $12.6 million in the same period of the prior year. The increase in cash used in investing activities was primarily driven by investment purchases to fund deferred compensation plans, and to a lesser extent by an increase in capital expenditures for the purchase of manufacturing equipment and facility upgrades in Europe, the United States, and Mexico.

Net cash used in financing activities was $26.0 million during the six months ended January 31, 2020, compared to $10.1 million in the same period of the prior year. The change was primarily due to a decrease in cash proceeds from the exercise of stock options and an increase in cash payments for employee taxes withheld from stock-based awards in the current six-month period.

On May 13, 2010, the Company completed a private placement of €75.0 million aggregate principal amount of senior unsecured notes to accredited institutional investors. The €75.0 million of senior notes consisted of €30.0 million aggregate principal amount of 3.71% Series 2010-A Senior Notes, which were repaid during fiscal 2017, and €45.0 million aggregate principal amount of 4.24% Series 2010-A Senior Notes, due May 13, 2020, with interest payable on the notes semiannually. This private placement was exempt from the registration requirements of the Securities Act of 1933. The notes have been fully and unconditionally guaranteed on an unsecured basis by the Company’s domestic subsidiaries.

On August 1, 2019, the Company and certain of its subsidiaries entered into an unsecured $200 million multi-currency revolving loan agreement with a group of five banks that replaced and terminated the Company’s previous loan agreement that had been entered into on September 25, 2015. Under the new revolving loan agreement, the Company has the option to select either a base interest rate (based upon the higher of the federal funds rate plus one-half of 1% or the prime rate of the Bank of Montreal plus a margin based on the Company’s consolidated net leverage ratio), or the Eurocurrency interest rate (at the LIBOR rate plus a margin based on the Company’s consolidated net leverage ratio) plus 1%. At the Company's option, and subject to certain conditions, the available amount under the revolving loan agreement may be increased from $200 million to $400 million. As of January 31, 2020, there were no borrowings outstanding on the credit facility, and there was no outstanding balances during the six months ended January 31, 2020. The Company had letters of credit outstanding under the loan agreement of $3.3 million as of January 31, 2020 and there was $196.7 million available for future borrowing, which can be increased to $396.7 million at the Company's option, subject to certain conditions. The revolving loan agreement has a final maturity date of August 1, 2024, as such, any borrowing would be classified as long-term on the condensed consolidated balance sheets.

The Company’s debt agreements require it to maintain certain financial covenants, including a ratio of debt to the trailing 12 months EBITDA, as defined in the debt agreements, of not more than a 3.25 to 1.0 ratio (leverage ratio) and the trailing 12 months EBITDA to interest expense of not less than a 3.0 to 1.0 ratio (interest expense coverage). As of January 31, 2020, the Company was in compliance with these financial covenants, with the leverage ratio, as defined by the agreements, equal to 0.0 to 1.0 and the interest expense coverage ratio equal to 75.7 to 1.0.

The Company's cash balances are generated and held in numerous locations throughout the world. At January 31, 2020, approximately 47% of the Company's cash and cash equivalents were held outside the United States. The Company's growth has historically been funded by a combination of cash provided by operating activities and debt financing. The Company believes that its cash flow from operating activities and its borrowing capacity are sufficient to fund its anticipated requirements for working capital, capital expenditures, common stock repurchases, scheduled debt repayments, and dividend payments for the next 12 months.

Off-Balance Sheet Arrangements

The Company does not have material off-balance sheet arrangements. The Company is not aware of factors that are reasonably likely to adversely affect liquidity trends, other than the risk factors described in this and other Company filings. However, the following additional information is provided to assist those reviewing the Company’s financial statements.

Purchase Commitments - The Company has purchase commitments for materials, supplies, services, and property, plant and equipment as part of the ordinary conduct of its business. In the aggregate, such commitments are not in excess of current market prices and are not material to the financial position of the Company. Due to the proprietary nature of many of the Company’s materials and processes, certain supply contracts contain penalty provisions for early termination. The Company does not believe a material amount of penalties will be incurred under these contracts based upon historical experience and current expectations.

Other Contractual Obligations - The Company does not have material financial guarantees or other contractual commitments that are reasonably likely to adversely affect liquidity.

Forward-Looking Statements

In this quarterly report on Form 10-Q, statements that are not reported financial results or other historic information are “forward-looking statements.” These forward-looking statements relate to, among other things, the Company's future financial position, business strategy, targets, projected sales, costs, income, capital expenditures, debt levels and cash flows, and plans and objectives of management for future operations.

The use of words such as “may,” “will,” “expect,” “intend,” “estimate,” “anticipate,” “believe,” “should,” “project” or “plan” or similar terminology are generally intended to identify forward-looking statements. These forward-looking statements by their nature address matters that are, to different degrees, uncertain and are subject to risks, assumptions, and other factors, some of which are beyond Brady's control, that could cause actual results to differ materially from those expressed or implied by such forward-looking statements. For Brady, uncertainties arise from:

  • Brady's ability to compete effectively or to successfully execute its strategy
  • Brady's ability to develop technologically advanced products that meet customer demands
  • Difficulties in protecting websites, networks, and systems against security breaches
  • Decreased demand for the Company's products
  • Raw material and other cost increases
  • Extensive regulations by U.S. and non-U.S. governmental and self-regulatory entities
  • Risks associated with the loss of key employees
  • Divestitures, contingent liabilities from divestitures and the failure to identify, integrate, and grow acquired companies
  • Litigation, including product liability claims
  • Foreign currency fluctuations
  • Changes in tax legislation and tax rates
  • Potential write-offs of Brady's substantial intangible assets
  • Numerous other matters of national, regional and global scale, including major public health issues and those of a political, economic, business, competitive, and regulatory nature contained from time to time in Brady's U.S. Securities and Exchange Commission filings, including, but not limited to, those factors listed in the “Risk Factors” section within Item 1A of Part I of Brady's Form 10-K for the year ended July 31, 2019.

These uncertainties may cause Brady's actual future results to be materially different than those expressed in its forward-looking statements. Brady does not undertake to update its forward-looking statements except as required by law.

Market risk

As filed, 158 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Refer to the Company’s annual report on Form 10-K for the year ended July 31, 2019. There has been no material change in this information since July 31, 2019.

Controls and procedures

As filed, 1,816 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Brady Corporation maintains a set of disclosure controls and procedures that are designed to ensure that information required to be disclosed by the Company in the reports filed by the Company under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by the Company in the reports the Company files under the Exchange Act is accumulated and communicated to the Company’s management, including the Company’s principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. The Company carried out an evaluation, under the supervision and with the participation of its management, including its President and Chief Executive Officer and its Chief Financial Officer and Treasurer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures pursuant to Rule 13a-15 of the Exchange Act. Based on that evaluation, the Company’s President and Chief Executive Officer and Chief Financial Officer and Treasurer concluded that the Company’s disclosure controls and procedures are effective as of the end of the period covered by this report.

There were no significant changes in the Company's internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the Company's most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2020-01-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Cost of revenue3 months2019-11-01 to 2020-01-31$137.5mus-gaap:CostOfGoodsAndServicesSold
Cost of revenue6 months2019-08-01 to 2020-01-31$283.1mus-gaap:CostOfGoodsAndServicesSold
Gross profit3 months2019-11-01 to 2020-01-31$139.1mus-gaap:GrossProfit
Gross profit6 months2019-08-01 to 2020-01-31$280.5mus-gaap:GrossProfit
Research and development3 months2019-11-01 to 2020-01-31$10.5mus-gaap:ResearchAndDevelopmentExpense
Research and development6 months2019-08-01 to 2020-01-31$21.5mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2019-11-01 to 2020-01-31$87.4mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2019-08-01 to 2020-01-31$176.9mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2019-11-01 to 2020-01-31$41.2mus-gaap:OperatingIncomeLoss
Operating income6 months2019-08-01 to 2020-01-31$82.1mus-gaap:OperatingIncomeLoss
Interest expense3 months2019-11-01 to 2020-01-31$647.0kus-gaap:InterestExpense
Interest expense6 months2019-08-01 to 2020-01-31$1.3mus-gaap:InterestExpense
Income tax3 months2019-11-01 to 2020-01-31$8.8mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2019-08-01 to 2020-01-31$12.9mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-11-01 to 2020-01-31$33.6mus-gaap:NetIncomeLoss
Net income6 months2019-08-01 to 2020-01-31$71.1mus-gaap:NetIncomeLoss
Diluted shares (weighted)3 months2019-11-01 to 2020-01-3153,827,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2019-08-01 to 2020-01-3153,781,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2019-08-01 to 2020-01-31$53.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2019-08-01 to 2020-01-31$13.1mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid6 months2019-08-01 to 2020-01-31$23.1mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2020-01-31$289.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2020-01-31$581.0mus-gaap:AssetsCurrent
Total assetsAt period end2020-01-31$1.22bnus-gaap:Assets
Current liabilitiesAt period end2020-01-31$216.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2020-01-31$315.9mus-gaap:Liabilities
Current portion of debtAt period end2020-01-31$49.6mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2020-01-31$899.9mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0000746598-20-000021. Last ingested by Listed: Nov 9, 2026, 17:29 ET. Listed shows no prices and gives no investment advice.